ProCE Banner Activity

How I Integrate Biomarkers Into the Management of Heart Failure

Clinical Thought
I describe how biomarkers such as BNP and NT-proBNP can help influence decisions about the diagnosis and prognosis of heart failure.

Released: October 10, 2016

Expiration: October 09, 2017

No longer available for credit.

Share

Faculty

Akshay Suvas Desai

Akshay Suvas Desai, MD, MPH

Associate Professor of Medicine
Department of Cardiovascular Medicine
Center for Advanced Heart Disease
Harvard Medical School
Director, Heart Failure Disease Management Program
Brigham and Womens Hospital
Boston, Massachusetts

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Novartis Pharmaceuticals Corporation

Faculty Disclosure

Primary Author

Akshay Suvas Desai, MD, MPH

Associate Professor of Medicine
Department of Cardiovascular Medicine
Center for Advanced Heart Disease
Harvard Medical School
Director, Heart Failure Disease Management Program
Brigham and Womens Hospital
Boston, Massachusetts

Akshay Suvas Desai, MD, MPH, has disclosed that he has received consulting fees from Janssen, Merck, Novartis, Relypsa, sanofi-aventis, and St Jude Medical and funds for research support and fees for non-CME services from Novartis.